Lyfebulb and Bristol Myers Squibb have announced the 10 finalists who will compete virtually for a $25,000 award to support the development of innovations that address unmet needs in multiple sclerosis (MS). The Lyfebulb-Bristol Myers Squibb 2021 “Addressing Unmet Needs in MS: An Innovation Challenge” will take place March 10–11 and will be virtual for the first time in the competition’s history. “MS is an ever-changing disease, and Bristol Myers Squibb is grateful to be…

You must be logged in to read/download the full post.